http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20090447-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
filingDate 2008-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c582204a59670a69ea1342cd986831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f57a1a01cfbff4167b45ff1a52288fd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9012efdb5a5d14a72969ab6e82806bd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7135b43f54db5fc5058d838eac38cd43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee446f2d2bd71e4623c875e2b12be6be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9d129b05044fd879ce3697c294bc16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b20f9363c20d3787495d68ea5649d8ca
publicationDate 2009-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20090447-A1
titleOfInvention BENCENSULFONIL-CHROMANE, THIOCHROMANE, TETRAHYDRONAPHTHALENE AND RELATED GAMMA SECRETASE INHIBITORS
abstract REFERS TO A COMPOUND OF FORMULA 1, WHERE X IS -O-, -S-, -S (O2) -, AMONG OTHERS; ---- IS OPTIONAL LINK; Y, Z ARE EACH N, C; Q IS RING OF 5-8 MEMBERS FUSED WITH A1 AND Q1; Q1 IS A RING OF 5-7 MEMBERS WITH A HETEROATOME SELECTED FROM N, O, S (O) AND S (O2) FUSED WITH Q; L1 IS HALOGEN, ALKYL, -CN, -CF3, -O- (C1-C6 ALKYL), AMONG OTHERS; Ar IS ARYL SUBSTITUTED OR NOT, HETEROARYL IS SUBSTITUTED OR NOT. A PREFERRED COMPOUND IS (5aR, 13aS) -11bR - [(4-CHLOROPHENYL) SULFONIL] -8,11-DIFLUORO-2,3,5a, 6,11b, 12,13,13a-OCTAHYDRO [1] BENZOPYRANE [4 ', 3': 5.6] PYRID [1,2-c] PYRIMIDIN-4 (1H) -ONE. SUCH COMPOUNDS ARE USEFUL GAMMA SECRETASE INHIBITORS IN THE TREATMENT OF ALZHEIMER
priorityDate 2007-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408141350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410714557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425876034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8404

Total number of triples: 37.